TRADING UPDATES: Aurrigo wins deal; Dekel palm oil output up
11th May 2026 13:59
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
| Price | 11.75p on 14-05-2026 at 16:30:01 |
|---|---|
| Change | -0.50p -4.08% |
| Buy | 12.00p |
| Sell | 11.50p |
| Last Trade: | Unknown 100,000.00 at 11.50p |
| Day's Volume: | 350,955 |
| Last Close: | 11.75p |
| Open: | 12.25p |
| ISIN: | GB00BLF79J41 |
| Day's Range | 11.75p - 12.25p |
| 52wk Range: | 5.25p - 13.00p |
| Market Capitalisation: | £29.50m |
| VWAP: | 11.90542p |
| Shares in Issue: | 251.08m |
Sector: Medical Services
Listed In: FTSE AIM All-Share,
Abingdon Healt. (ABDX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 100,000 | 11.50p | Ordinary |
16:27:36 - 14-May-26 |
| Buy* | 30,000 | 11.81p | Ordinary |
16:06:14 - 14-May-26 |
| Buy* | 8,467 | 11.81p | Ordinary |
15:57:56 - 14-May-26 |
| Buy* | 8,467 | 11.81p | Ordinary |
15:42:13 - 14-May-26 |
| Sell* | 8 | 11.50p | SI Trade |
15:41:49 - 14-May-26 |
| Buy* | 30,000 | 12.15p | Ordinary |
15:30:49 - 14-May-26 |
| Unknown* | 50,000 | 12.00p | Ordinary |
15:20:58 - 14-May-26 |
| Buy* | 40 | 12.50p | SI Trade |
15:20:53 - 14-May-26 |
| Buy* | 771 | 12.50p | SI Trade |
15:20:53 - 14-May-26 |
| Buy* | 200 | 12.50p | SI Trade |
15:20:53 - 14-May-26 |
Abingdon Healt. (ABDX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 11th May 2026 7:00 am | RNS-R | Launch of LVOne Stroke Test by UpFront Diagnostics |
| 7th May 2026 5:38 pm | RNS | Holding(s) in Company |
| 6th May 2026 7:00 am | RNS-R | Update on Partnership with 4TEEN4 Pharmaceuticals |
| 21st Apr 2026 7:00 am | RNS | Admission to trading on OTCQB in the US |
| 15th Apr 2026 7:00 am | RNS | EMI Share Option Scheme |
| 14th Apr 2026 7:00 am | RNS | Trading to commence on the OTCQB in the US |
| 30th Mar 2026 7:00 am | RNS | £4.8m contracts awarded |
| 17th Mar 2026 7:00 am | RNS | Half-year Financial Report |
| 17th Mar 2026 7:00 am | RNS | Half-year Financial Report |
| 12th Mar 2026 7:00 am | RNS | $2.5m Contract for clinical self-test development |